Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 9111-9120 Newer>

Chemistry World June 24, 2015 Matthew Gunther	Allergan to buy out Kythera Biopharma for $2.1bn The pharma firm Allergan will acquire Kythera Biopharmaceuticals in a $2.1 billion deal.
Chemistry World June 24, 2015 Patrick Walter	Legal in theory Governments around the world are faced with the particularly tricky problem of what they should do about 'legal highs'.
Chemistry World June 19, 2015 Rebecca Trager	Alnylam accuses Dicerna of stealing trade secrets The US biopharmaceutical company Alnylam has filed a 'trade secret misappropriation' lawsuit against fellow Cambridge-based firm Dicerna.
Information Today June 18, 2015	BioMed Central Agrees to Publish Mutation Research Journal BioMed Central partnered with the Japanese Environmental Mutagen Society to publish the society's official journal, Genes and Environment.
Chemistry World June 16, 2015 Simon Hadlington	Regulators have drug firms chasing phantom impurity Potentially effective sulfonic acid salt drug formulations have been discouraged by regulators on the basis of a myth.
Chemistry World June 10, 2015	The peak of success The 2015 Chemistry World entrepreneur of the year is Ray Fisher of Peakdale Molecular.
Chemistry World June 11, 2015 Sarah Houlton	Companies clamour for CAR-T The biopharmaceutical industry is getting excited about chimeric antigen receptor T-cells, or CAR-T cells, designed to harness the cell-killing power of the immune system.
Chemistry World June 9, 2015 Phillip Broadwith	Opko deepens diagnostics with $1.5bn lab buyout Healthcare firm Opko is aiming to enhance its position in diagnostic technology by agreeing to buy clinical diagnostics service BioReference Laboratories.
Chemistry World June 9, 2015 Phillip Broadwith	Vertex nabs rights to cystic fibrosis molecules Specialist pharmaceutical firm Vertex has struck a development deal with start-up Parion Sciences to develop Parion's investigational drug candidates for respiratory diseases, including cystic fibrosis.
Chemistry World June 8, 2015 Rebecca Trager	NIH drug manufacturing unit shut down The halt could potentially affect 46 clinical trials, and about 250 patients who are either receiving, or about to receive, products manufactured at the facility.
<Older 9111-9120 Newer> Return to current articles.